FMC

FMC · NYSE

$5.31−$0.05 (−0.93%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $5.36

FMC analyst rating

HoldConsensus of 15 analysts over the last 12 months. 27% rate it a buy.

Strong buy0
Buy4
Hold10
Underperform1
Sell0

12-month price target · 19 analysts

Average $13.75 (+159.0% upside)

Low: $11.11
Now: $5.31
High: $22.05

Upgrades and downgrades

The latest rating actions, newest first

FMC analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Citigroup	Oct 19, 2026	Maintains	Neutral	$12.00 → $6.00	53%
Barclays	Oct 16, 2026	Maintains	Underweight	$9.00 → $4.00	48%
BMO Capital	Oct 16, 2026	Maintains	Market Perform	$11.00 → $7.50	45%
Jefferies	Oct 16, 2026	Downgrade	Buy → Hold	$14.00 → $5.00	57%
RBC Capital	Oct 15, 2026	Maintains	Sector Perform	$11.00 → $9.00	46%
Mizuho	Oct 13, 2026	Maintains	Outperform	$15.00 → $12.00	71%
UBS	Oct 5, 2026	Maintains	Neutral	$12.00 → $10.00	49%
Keybanc	Sep 11, 2026	Initiates	Overweight	$16.00	30%
RBC Capital	Aug 3, 2026	Maintains	Sector Perform	$12.00 → $11.00	46%
Citigroup	Jul 31, 2026	Maintains	Neutral	$14.00 → $12.00	53%

The case for and against

Updated Oct 23, 2025

Bull case

FMC's management expresses strong confidence in achieving an implied EBITDA of approximately $600 million in the second half of the year, aided by improved volumes following effective channel sell-ins during the first half. The company anticipates a more robust volume recovery in the second half, particularly benefiting from the Latin America seasonal gains. Additionally, positive momentum has been observed in the U.S. during the second quarter, further supporting the favorable outlook for the company's financial performance.

Bear case

FMC experienced a significant 9% year-over-year price decline in the first quarter, attributed largely to increased competition in Brazil, despite stronger sales in that region. Additionally, this price drop coincided with a 1% decline in volume, indicating potential weaknesses in demand. The company's below-consensus guidance for the second quarter likely exacerbated investor concerns, contributing to the underperformance of its shares.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.